BioSpace News Archive

BioCapital

BioMarker Strategies to Present at Biotech Showcase 2020 in San Francisco During J.P. Morgan Healthcare Conference Week

Will also Participate in BIO One on One Partnering at JPM, and in the Life Science Nation’s RESI San Francisco Conference

January 6, 2020
·
3 min read
Clinigen and Orphazyme launch an Early Access Program for arimoclomol in patients with Niemann-Pick disease type C

Clinigen Group plc has partnered with Orphazyme A/S, a global biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, to introduce and administer an Early Access Program for arimoclomol in patients with Niemann-Pick disease type C in the US.

January 6, 2020
·
3 min read
Business

Smile Direct Club Launches New Line of Oral Care Products Available Exclusively at Walmart

SmileDirectClub announced the launch of an end-to-end solution to keep teeth fresh, clean, bright, and healthy: a suite of affordable yet premium oral care products available exclusively at Walmart U.S. stores and Walmart.com.

January 6, 2020
·
7 min read
Job Trends

Critical Shortage of Blood and Blood Components

Vitalant, one of the largest national nonprofit blood banks, is declaring a critical shortage of blood.

January 6, 2020
·
3 min read
Bausch Health To Participate At The 38th Annual J.P. Morgan Healthcare Conference

Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that Joseph C. Papa, chairman and chief executive officer, is scheduled to participate at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, Jan. 13, 2019 at 1:30 p.m. PT (4:30 p.m. ET).

January 6, 2020
·
1 min read
Drug Development

Protagonist Therapeutics Initiates Phase 2 Study of Novel Hepcidin Mimetic PTG-300 in the Treatment of Patients with Hereditary Hemochromatosis

Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today announced that a Phase 2 study of its novel hepcidin mimetic PTG-300 in patients with hereditary hemochromatosis has been initiated

January 6, 2020
·
7 min read
Drug Development

BAVENCIO Significantly Improved Overall Survival in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced the Phase III JAVELIN Bladder 100 study met its primary endpoint of overall survival (OS) at the planned interim analysis.

January 6, 2020
·
22 min read
Biotech Beach

Applied BioCode Receives FDA 510(k) Clearance for Syndromic Respiratory Pathogen Panel

Applied BioCode announced that it has received 510(k) Clearance from the U.S. Food and Drug Administration (FDA) for its BioCode® Respiratory Pathogen Panel (RPP) for use on the BioCode® MDx-3000 System.

January 6, 2020
·
2 min read
Deals

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan. 6, 2020

Verastem, Inc., a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, announced the grant of options to purchase 110,963 shares of its common stock to eight new employees.

January 6, 2020
·
2 min read
Business

AVEO Announces Appointment of Erick J. Lucera as Chief Financial Officer

AVEO Oncology announced the appointment of Erick Lucera as chief financial officer. Mr. Lucera will be responsible for managing all aspects of the Company’s financial and accounting functions.

January 6, 2020
·
6 min read